MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ ? BillionToOne, Inc. , a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, ...
As of September 30, 2025, BillionToOne held approximately $195.2 million in cash and cash equivalents. The Company raised gross proceeds of $314.0 million from its IPO, which closed on November 7, ...
Shard Diagnostic has become the latest company to join the University of Nottingham's investment portfolio, supported through ...
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...
A stronger domestic industry will not just boost the local industry and reduce the import bill but also ensure that ...
Testmate Health and Intermountain Health have entered a strategic collaboration and investment agreement to expedite the ...
Core to Seegene Mexico are the Allplex and Anyplex HPV 28 Detection assays – real-time multiplexing PCR tests that identify ...